ITCA 650 20/60 mcg/day

DRUG2 trials

Sponsors

Intarcia Therapeutics

Conditions

Diabetes Mellitus, Type 2Healthy

Phase 1

Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

CompletedNCT02641899

Intarcia TherapeuticsHealthy

Start: 2015-12-31End: 2016-03-31Updated: 2017-01-27

Phase 3

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin

TerminatedNCT03060980

Intarcia TherapeuticsDiabetes Mellitus, Type 2

Start: 2017-03-03End: 2018-01-26Updated: 2019-03-07